← back to search

George Sakoulas

University of California San Diego · US
Area of research
Infectious Diseases · Clinical Biochemistry
Research interest
Research interests include Antimicrobial Resistance in Staphylococcus, Bacterial Identification and Susceptibility Testing, Antibiotics Pharmacokinetics and Efficacy, and Infective Endocarditis Diagnosis and Management.
h-index
66
citations
16,432
works
413
NIH funding
primary concept
email

Recent publications

Neutrophil Extracellular Traps: An Emerging Therapeutic Target to Improve Infectious Disease Outcomes
The Journal of Infectious Diseases 2024cited by 27position: middledoi
Dalbavancin Sequential Therapy for Gram-Positive Bloodstream Infection: A Multicenter Observational Study
Infectious Diseases and Therapy 2024cited by 14position: middledoi
Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and β-lactam chemistry
The Lancet Infectious Diseases 2023cited by 15position: lastdoi
Current Paradigms of Combination Therapy in Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Bacteremia: Does it Work, Which Combination, and For Which Patients?
Clinical Infectious Diseases 2021cited by 66position: lastdoi
Repurposed drugs block toxin-driven platelet clearance by the hepatic Ashwell-Morell receptor to clear <i>Staphylococcus aureus</i> bacteremia
Science Translational Medicine 2021cited by 55position: middledoi
Acute Psychosis Due to Anti-N-Methyl D-Aspartate Receptor Encephalitis Following COVID-19 Vaccination: A Case Report
Frontiers in Neurology 2021cited by 51position: lastdoi
Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia
Infectious Diseases and Therapy 2021cited by 30position: lastdoi
Mortality Risk Profiling of Staphylococcus aureus Bacteremia by Multi-omic Serum Analysis Reveals Early Predictive and Pathogenic Signatures
Cell 2020cited by 121position: middledoi
Intravenous Immunoglobulin Plus Methylprednisolone Mitigate Respiratory Morbidity in Coronavirus Disease 2019
Critical Care Explorations 2020cited by 50position: firstdoi
Use of Intravenous Immunoglobulin (Prevagen or Octagam) for the Treatment of COVID-19: Retrospective Case Series
Respiration 2020cited by 36position: middledoi
Synergistic Effects of Pulsed Lavage and Antimicrobial Therapy Against Staphylococcus aureus Biofilms in an in-vitro Model
Frontiers in Medicine 2020cited by 18position: middledoi
Clinical Data on Daptomycin plus Ceftaroline versus Standard of Care Monotherapy in the Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
Antimicrobial Agents and Chemotherapy 2019cited by 188position: lastdoi
Multicenter Cohort of Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia Receiving Daptomycin Plus Ceftaroline Compared With Other MRSA Treatments
Open Forum Infectious Diseases 2019cited by 87position: middledoi
Cefazolin and Ertapenem Salvage Therapy Rapidly Clears Persistent Methicillin-Susceptible Staphylococcus aureus Bacteremia
Clinical Infectious Diseases 2019cited by 54position: lastdoi
Bacterial Cytological Profiling (BCP) as a Rapid and Accurate Antimicrobial Susceptibility Testing Method for Staphylococcus aureus
EBioMedicine 2016cited by 83position: middledoi
Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR<i>Stenotrophomonas maltophilia</i>
Journal of Antimicrobial Chemotherapy 2016cited by 63position: middledoi
Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial
Journal of Antimicrobial Chemotherapy 2016cited by 59position: middledoi
Azithromycin Synergizes with Cationic Antimicrobial Peptides to Exert Bactericidal and Therapeutic Activity Against Highly Multidrug-Resistant Gram-Negative Bacterial Pathogens
EBioMedicine 2015cited by 283position: middledoi
β-Lactam combinations with daptomycin provide synergy against vancomycin-resistant <i>Enterococcus faecalis</i> and <i>Enterococcus faecium</i>
Journal of Antimicrobial Chemotherapy 2015cited by 136position: middledoi
When sepsis persists: a review of MRSA bacteraemia salvage therapy
Journal of Antimicrobial Chemotherapy 2015cited by 71position: middledoi
Penicillin Binding Protein 1 Is Important in the Compensatory Response of Staphylococcus aureus to Daptomycin-Induced Membrane Damage and Is a Potential Target for β-Lactam–Daptomycin Synergy
Antimicrobial Agents and Chemotherapy 2015cited by 64position: middledoi
Antimicrobial Salvage Therapy for Persistent Staphylococcal Bacteremia Using Daptomycin Plus Ceftaroline
Clinical Therapeutics 2014cited by 181position: firstdoi
Daptomycin in Combination With Other Antibiotics for the Treatment of Complicated Methicillin-Resistant Staphylococcus aureus Bacteremia
Clinical Therapeutics 2014cited by 79position: lastdoi
Defining Daptomycin Resistance Prevention Exposures in Vancomycin-Resistant Enterococcus faecium and E. faecalis
Antimicrobial Agents and Chemotherapy 2014cited by 69position: middledoi
Potent synergy of ceftobiprole plus daptomycin against multiple strains of Staphylococcus aureus with various resistance phenotypes
Journal of Antimicrobial Chemotherapy 2014cited by 64position: middledoi
Heterogeneity of <i>mprF</i> Sequences in Methicillin-Resistant Staphylococcus aureus Clinical Isolates: Role in Cross-Resistance between Daptomycin and Host Defense Antimicrobial Peptides
Antimicrobial Agents and Chemotherapy 2014cited by 63position: middledoi
Avoiding the Perfect Storm: The Biologic and Clinical Case for Reevaluating the 7-Day Expectation for Methicillin-Resistant Staphylococcus aureus Bacteremia Before Switching Therapy
Clinical Infectious Diseases 2014cited by 54position: lastdoi
A Current Perspective on Daptomycin for the Clinical Microbiologist
Clinical Microbiology Reviews 2013cited by 242position: lastdoi
Nafcillin enhances innate immune-mediated killing of methicillin-resistant Staphylococcus aureus
Journal of Molecular Medicine 2013cited by 142position: firstdoi
A multicentre evaluation of the effectiveness and safety of high-dose daptomycin for the treatment of infective endocarditis
Journal of Antimicrobial Chemotherapy 2013cited by 103position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Victor Nizet · CNR de la Résistance aux Antibiotiques19 papers (2012–2024)Warren E. Rose · University of Wisconsin–Madison14 papers (2012–2021)Michael J. Rybak · Rockefeller University11 papers (2012–2023)Poochit Nonejuie · Mahidol University11 papers (2013–2016)Ravina Kullar · Twitter (United States)9 papers (2013–2021)Joshua Olson · University of California San Diego8 papers (2013–2021) · 7 papers (2019–2024) · 7 papers (2013–2021)Joseph Pogliano · University of California San Diego7 papers (2012–2015)Joe Pogliano · University of California San Diego6 papers (2013–2016) · 5 papers (2012–2014)Mary E. Hensler · University of California San Diego4 papers (2012–2015)Abhay Dhand · Jackson Laboratory4 papers (2012–2014)Sara E. Cosgrove · University of Baltimore3 papers (2012–2013)Romney M. Humphries · Vanderbilt University Medical Center3 papers (2012–2013)Andrew D. Berti · University of Saskatchewan3 papers (2012–2015)Anthony M. Casapao · University of Florida Health3 papers (2013–2014)Ryan Tewhey · Tufts University3 papers (2012–2013)Cheryl Okumura · Occidental College2 papers (2013–2014)Michael R. Yeaman · LAC+USC Medical Center2 papers (2013–2014)